Bioporto A/S
CSE:BIOPOR
Bioporto A/S
Cash Interest Paid
Bioporto A/S
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioporto A/S
CSE:BIOPOR
|
Cash Interest Paid
kr357k
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Cash Interest Paid
kr35m
|
CAGR 3-Years
43%
|
CAGR 5-Years
12%
|
CAGR 10-Years
80%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash Interest Paid
kr24m
|
CAGR 3-Years
94%
|
CAGR 5-Years
48%
|
CAGR 10-Years
28%
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash Interest Paid
€15.2m
|
CAGR 3-Years
102%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash Interest Paid
kr14.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Saniona AB
STO:SANION
|
Cash Interest Paid
kr8.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
Bioporto A/S
Glance View
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.
See Also
What is Bioporto A/S's Cash Interest Paid?
Cash Interest Paid
357k
DKK
Based on the financial report for Sep 30, 2024, Bioporto A/S's Cash Interest Paid amounts to 357k DKK.
What is Bioporto A/S's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
-52%
Over the last year, the Cash Interest Paid growth was -45%. The average annual Cash Interest Paid growth rates for Bioporto A/S have been -52% over the past three years .
You don't have any saved screeners yet